Company Filing History:
1 out of 832,843 Years Active: 2003
Title: **Haruo Ishiyama: Pioneer in Gene Therapy for Arteriosclerosis**
Introduction
Haruo Ishiyama is an innovative inventor based in Kanagawa, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the area of gene therapy. With one patent to his name, Ishiyama's work stands at the intersection of molecular biology and medical treatment, addressing crucial health issues.
Latest Patents
Ishiyama holds a patent titled "Recombinant DNA comprising DNA coding for myosin heavy chain SM1 iso-form protein inserted into vector DNA microorganism carrying the recombinant DNA, and an agent for treatment of arteriosclerosis comprising the recombinant DNA." This patent relates to recombinant DNA that encodes smooth-muscle-type myosin heavy chain SM1 isoform protein, which is inserted into vector DNA. The microorganism carrying this recombinant DNA can serve as a powerful agent for treating arteriosclerosis, particularly in the context of gene therapy post-percutaneous transluminal coronary angioplasty (PTCA) procedures.
Career Highlights
Throughout his career, Haruo Ishiyama has focused on developing innovative solutions to complex medical problems. His work on recombinant DNA technology opens new avenues for treatment strategies aimed at cardiovascular diseases. Ishiyama’s research is instrumental in improving the effectiveness of therapies for patients suffering from conditions related to arterial blockages.
Collaborations
In his professional journey, Ishiyama has collaborated with notable colleagues such as Kazuhide Hasegawa and Emi Arakawa. Their combined expertise and teamwork contribute to the advancement of research in gene therapy and enhance the potential applications of their inventions.
Conclusion
Haruo Ishiyama is a respected figure in the field of biotechnology with a focus on gene therapy applications. His patent represents a significant advancement in the treatment of arteriosclerosis, showcasing the vital role of innovations in addressing health challenges. As research in this area continues to evolve, Ishiyama's contributions will likely pave the way for future developments in medical technology.